Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Volin

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
European Journal of Haematology|January 1, 1989
Haem arginate treatment for hereditary sideroblastic anaemiaL Volin
Acta Haematologica|January 1, 1990
Pure red-cell aplasia of long duration after major ABO-incompatible bone marrow transplantationL Volin, T Ruutu
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1989
[Allogeneic and autologous bone marrow transplantation in managing malignant blood diseases]L Volin, T Ruutu
British Journal of Haematology|April 1, 1987
Haem arginate as a treatment for myelodysplastic syndromesT Ruutu, L Volin, R Tenhunen
Bone Marrow Transplantation|July 1, 1990
Fatal rhabdomyolysis as a complication of bone marrow transplantationL Volin, G Järventie, T Ruutu
Tissue Antigens|March 4, 2009
Domestic and foreign donor candidates result in differential probability of matching minor histocompatibility antigens--relevance of selection for hematopoietic stem cell transplantationH Turpeinen, L Volin, J Partanen
Research Communications in Chemical Pathology and Pharmacology|March 1, 1989
Effect of exogenous heme on hepatic iron-load and changes induced in hepatic heme metabolism by chronic iron-loadL Volin, E Vuori, R Tenhunen
Transplantation Proceedings|June 1, 1988
Low incidence of severe acute and chronic graft-versus-host disease as a result of prolonged cyclosporine prophylaxis and early aggressive treatment with corticosteroidsT Ruutu, L Volin, E Elonen
Leukemia Research|January 1, 1988
Heme arginate treatment for myelodysplastic syndromesL Volin, T Ruutu, S Knuutila, et al.
Bone Marrow Transplantation|May 1, 1989
In situ hybridization using a Y-specific probe--a sensitive method for distinguishing residual male recipient cells from female donor cells in bone marrow transplantationM Wessman, T Ruutu, L Volin, et al.
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
European Journal of Haematology|January 1, 1989
Haem arginate treatment for hereditary sideroblastic anaemiaL Volin
Acta Haematologica|January 1, 1990
Pure red-cell aplasia of long duration after major ABO-incompatible bone marrow transplantationL Volin, T Ruutu
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1989
[Allogeneic and autologous bone marrow transplantation in managing malignant blood diseases]L Volin, T Ruutu
British Journal of Haematology|April 1, 1987
Haem arginate as a treatment for myelodysplastic syndromesT Ruutu, L Volin, R Tenhunen
Bone Marrow Transplantation|July 1, 1990
Fatal rhabdomyolysis as a complication of bone marrow transplantationL Volin, G Järventie, T Ruutu
Tissue Antigens|March 4, 2009
Domestic and foreign donor candidates result in differential probability of matching minor histocompatibility antigens--relevance of selection for hematopoietic stem cell transplantationH Turpeinen, L Volin, J Partanen
Research Communications in Chemical Pathology and Pharmacology|March 1, 1989
Effect of exogenous heme on hepatic iron-load and changes induced in hepatic heme metabolism by chronic iron-loadL Volin, E Vuori, R Tenhunen
Transplantation Proceedings|June 1, 1988
Low incidence of severe acute and chronic graft-versus-host disease as a result of prolonged cyclosporine prophylaxis and early aggressive treatment with corticosteroidsT Ruutu, L Volin, E Elonen
Leukemia Research|January 1, 1988
Heme arginate treatment for myelodysplastic syndromesL Volin, T Ruutu, S Knuutila, et al.
Bone Marrow Transplantation|May 1, 1989
In situ hybridization using a Y-specific probe--a sensitive method for distinguishing residual male recipient cells from female donor cells in bone marrow transplantationM Wessman, T Ruutu, L Volin, et al.
Pageof 14